101 related articles for article (PubMed ID: 7137099)
1. Precision in estrogen and progesterone receptor assays. Results of the first CAP pilot survey.
Oxley DK; Haven GT; Wittliff JL; Gilbo D
Am J Clin Pathol; 1982 Oct; 78(4 Suppl):587-96. PubMed ID: 7137099
[TBL] [Abstract][Full Text] [Related]
2. Quality control study of estradiol and progesterone receptor determination.
Vermousek I; Számel I
Neoplasma; 1988; 35(3):307-14. PubMed ID: 3405339
[TBL] [Abstract][Full Text] [Related]
3. Hormone receptors in breast cancer. Analytic accuracy of contemporary assays.
Oxley DK
Arch Pathol Lab Med; 1984 Jan; 108(1):20-3. PubMed ID: 6546331
[TBL] [Abstract][Full Text] [Related]
4. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
[TBL] [Abstract][Full Text] [Related]
5. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer.
Biesterfeld S; Veuskens U; Schmitz FJ; Amo-Takyi B; Böcking A
Anticancer Res; 1996; 16(5A):2497-500. PubMed ID: 8917341
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
7. An approach to preliminary studies of interlaboratory comparative results for estrogen and progesterone receptors.
Tubbs RR
J Cell Biochem Suppl; 1994; 19():36-9. PubMed ID: 7823603
[TBL] [Abstract][Full Text] [Related]
8. Biochemically estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Immunocytochemical hormone receptors and prognostic factors.
Keshgegian AA
Arch Pathol Lab Med; 1994 Mar; 118(3):240-4. PubMed ID: 8135626
[TBL] [Abstract][Full Text] [Related]
9. [The estrogen receptor/progesterone receptor quotient as an index of the transcriptional activity of estrogen receptors in breast cancer].
Navarro MA; Díez Gibert O; Fernández-Montolí ME; Rosel P; Bonnin MR
Med Clin (Barc); 1995 May; 104(18):681-2. PubMed ID: 7769876
[TBL] [Abstract][Full Text] [Related]
10. Nuclear areas in breast cancer: relationship with estrogen and progesterone receptor expression.
Maiorana A; Cavallari V; Bagni A; Ussia F; Maiorana MC; Fano RA
Anal Cell Pathol; 1996 Aug; 11(3):199-209. PubMed ID: 8888955
[TBL] [Abstract][Full Text] [Related]
11. Variation of estrogen and progesterone receptor status in breast cancer.
Alanko A
Ann Clin Res; 1985; 17(1):10-4. PubMed ID: 4015025
[TBL] [Abstract][Full Text] [Related]
12. Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer.
Mann GB; Fahey VD; Feleppa F; Buchanan MR
J Clin Oncol; 2005 Aug; 23(22):5148-54. PubMed ID: 16051956
[TBL] [Abstract][Full Text] [Related]
13. The stability of estrogen and progesterone receptors in patients receiving preoperative chemotherapy for locally advanced breast carcinoma.
Jain V; Landry M; Levine EA
Am Surg; 1996 Feb; 62(2):162-5. PubMed ID: 8554195
[TBL] [Abstract][Full Text] [Related]
14. [Western blot analysis and flow cytometric analysis of estrogen and progesterone receptors in fixed breast cancer cells].
Tao DD; Jiang M; Wu JH; Feng YD; Gong JP
Ai Zheng; 2004 Mar; 23(3):339-41. PubMed ID: 15025971
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
[TBL] [Abstract][Full Text] [Related]
16. Seasonal variation in estrogen and progesterone receptor levels in breast cancer--a factor in data interpretation.
Vyzula R; Zaloudík J; Dusek L; Vermousek I
Neoplasma; 2001; 48(1):19-25. PubMed ID: 11327533
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
[TBL] [Abstract][Full Text] [Related]
18. Assay of estrogen and progesterone receptors in small samples of breast cancer: II. The conventional procedure compared to the mathematical one.
Viticchi C; Basso A; Piantanelli L; Zaia A
Boll Soc Ital Biol Sper; 1994; 70(8-9):229-34. PubMed ID: 7893481
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor status in breast cancer.
Wright CJ
Can J Surg; 1980 Jul; 23(4):316-7. PubMed ID: 7417890
[TBL] [Abstract][Full Text] [Related]
20. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
